Children Randomized to Long-Acting Insulin Glargine or Determir from Diagnosis of Type 1 Diabetes Mellitus Have Lower HbA1c after One Year as Compared to Those Randomized to NPH Insulin

Nph Insulin ◽

Acting Insulin ◽

One Year ◽

For children with type 1 diabetes mellitus, how do (ultra-)long-acting insulin analogs compare with neutral protamine Hagedorn (NPH) insulin?

Cochrane Clinical Answers ◽

10.1002/cca.3656 ◽

2021 ◽

Author(s):

Jane Burch ◽

Sera Tort ◽

Christopher Bunt

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Analogs ◽

Nph Insulin ◽

Acting Insulin ◽

Neutral Protamine Hagedorn ◽

P02-9 Better first year HbA1c in type 1 diabetes mellitus adolescents on long acting insulin analogs vs. NPH insulin is not associated with reversal of their IGF-I deficiency

Growth Hormone & IGF Research ◽

10.1016/s1096-6374(12)60135-x ◽

2012 ◽

Vol 22 ◽

pp. S51-S52

Author(s):

J. Salemyr ◽

K. Ekströ ◽

E. Ortqvist ◽

M. Pulkkinen ◽

A.-L. Brorsson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

First Year ◽

Insulin Analogs ◽

Nph Insulin ◽

Acting Insulin ◽

Igf I ◽

Intermediate acting versus long acting insulin for type 1 diabetes mellitus

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd006297.pub2 ◽

2008 ◽

Cited By ~ 7

Author(s):

Moshe Vardi ◽

Eyal Jacobson ◽

Asaph Nini ◽

Haim Bitterman

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Acting Insulin ◽

Intermediate acting versus long acting insulin for type 1 diabetes mellitus

10.1002/14651858.cd006297 ◽

2006 ◽

Author(s):

M Vardi ◽

A Nini

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Acting Insulin ◽

Ultra-long acting insulin versus long-acting insulin for type 1 diabetes mellitus

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd011102.pub2 ◽

2018 ◽

Author(s):

Cheow Peng Ooi ◽

Tzer Hwu Ting ◽

Munn Sann Lye

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Acting Insulin ◽

For adults with type 1 diabetes mellitus, how do (ultra-)long-acting insulin analogs compare?

Cochrane Clinical Answers ◽

10.1002/cca.3655 ◽

2021 ◽

Author(s):

Jane Burch ◽

Sera Tort ◽

Christopher Bunt

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Analogs ◽

Acting Insulin ◽

Diabetic ketoacidosis, long-acting insulin analogs and pediatric type 1 diabetes mellitus

Nature Reviews Endocrinology ◽

10.1038/nrendo.2010.60 ◽

2010 ◽

Vol 6 (6) ◽

pp. 298-298

Author(s):

Carol Wilson

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Diabetic Ketoacidosis ◽

Insulin Analogs ◽

Acting Insulin ◽

Long Acting ◽

Pediatric Type 1 Diabetes

Glycaemic Control and Hypoglycaemia in Children, Adolescents and Young Adults with Unstable Type 1 Diabetes Mellitus Treated with Insulin Glargine or Intermediate-acting Insulin

Journal of Pediatric Endocrinology and Metabolism ◽

10.1515/jpem.2007.20.4.517 ◽

2007 ◽

Vol 20 (4) ◽

Cited By ~ 9

Author(s):

J. Herwig ◽

G. Scholl-Schilling ◽

H. Böhles

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Young Adults ◽

Glycaemic Control ◽

Insulin Glargine ◽

Acting Insulin ◽

Intermediate Acting Insulin ◽

Unstable Type

Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy - Original Article

Journal of Clinical Research in Pediatric Endocrinology ◽

10.4274/jcrpe.v1i4.56 ◽

2009 ◽

Vol 1 (4) ◽

pp. 181-187 ◽

Cited By ~ 5

Author(s):

Bumin Nuri Dündar ◽

Nihal Dündar ◽

Erdal Eren

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Therapy ◽

Intensive Insulin Therapy ◽

Insulin Detemir ◽

Efficacy And Safety ◽

Nph Insulin

Ultra-long acting insulin versus long-acting insulin for type 1 diabetes mellitus

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd011102 ◽

2014 ◽

Cited By ~ 1

Author(s):

Cheow Peng Ooi ◽

Tzer Hwu Ting ◽

Seng Cheong Loke

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Acting Insulin ◽